Literature DB >> 33443932

Vascular activation is a strong predictor of mortality in coronavirus disease 2019 patients on the ICU.

Raf De Jongh1, Marisa Ninivaggi2, Dieter Mesotten1, Cui Bai2, Berend Marcus1, Dana Huskens2, Hendrik Stragier1, Adam Miszta2, Jasmine Verbruggen1, Romy M W de Laat-Kremers2, Jef Grieten1, Bas de Laat2.   

Abstract

Respiratory failure in coronavirus disease 2019 (COVID-19) patients is one of the most frequent causes for referral to the ICU. A significant percentage of these patients does not survive the infection due to thromboembolic complications. Furthermore, the vascular system seems also to be involved in the pathogenesis. To investigate the role of hemostasis and endothelium on the outcome of COVID-19 patients admitted to the ICU. Blood was drawn from 16 ICU COVID-19 patients for hemostatic analysis. Patients were followed-up till discharge (n = 11) or death (n = 5). Parameters related to both coagulation and fibrinolysis, though disturbed, were not associated with mortality. Contrarily, activated Von Willebrand factor was increased and ADAMTS13 levels were decreased by two-fold in nonsurvivors compared with survivors. Our data established the involvement of the Von Willebrand factor-ADAMTS13 axis in the COVID-19 pathogenesis, thereby demonstrating that these plasma proteins seem to be strong predictors for ICU mortality.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33443932     DOI: 10.1097/MBC.0000000000001007

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  5 in total

1.  Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S.

Authors:  Bas de Laat; Hendrik Stragier; Romy de Laat-Kremers; Marisa Ninivaggi; Dieter Mesotten; Steven Thiessen; Kristien Van Pelt; Mark Roest; Joris Penders; Pascal Vanelderen; Dana Huskens; Raf De Jongh; Margot Vander Laenen; Tom Fivez; Hugo Ten Cate; Rene Heylen; Line Heylen; Deborah Steensels
Journal:  Front Cardiovasc Med       Date:  2022-07-29

Review 2.  Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis.

Authors:  Xin Xu; Yao Feng; Yitong Jia; Xiao Zhang; Long Li; Xuesong Bai; Liqun Jiao
Journal:  Thromb Res       Date:  2022-08-18       Impact factor: 10.407

3.  Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98.

Authors:  Romy de Laat-Kremers; Raf De Jongh; Marisa Ninivaggi; Aernoud Fiolet; Rob Fijnheer; Jasper Remijn; Bas de Laat
Journal:  Front Immunol       Date:  2022-09-28       Impact factor: 8.786

4.  Endotheliopathy marked by high von Willebrand factor (vWF) antigen in COVID-19 is associated with poor outcome: a systematic review and meta-analysis.

Authors:  Arief Wibowo; Raymond Pranata; Michael Anthonius Lim; Mohammad Rizki Akbara; Januar Wibawa Martha
Journal:  Int J Infect Dis       Date:  2021-06-27       Impact factor: 12.074

Review 5.  Assessing Plasmin Generation in Health and Disease.

Authors:  Adam Miszta; Dana Huskens; Demy Donkervoort; Molly J M Roberts; Alisa S Wolberg; Bas de Laat
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.